NasdaqGS - Delayed Quote USD

Medpace Holdings, Inc. (MEDP)

389.77 -7.79 (-1.96%)
At close: April 25 at 4:00 PM EDT
389.77 0.00 (0.00%)
After hours: April 25 at 4:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,962,812.00
1,885,842.00
1,459,996.00
1,142,377.00
925,925.00
Cost of Revenue
1,413,354.00
1,361,337.00
1,027,558.00
814,222.00
647,199.00
Gross Profit
549,458.00
524,505.00
432,438.00
328,155.00
278,726.00
Operating Expense
194,768.00
187,680.00
153,741.00
129,540.00
111,684.00
Operating Income
354,690.00
336,825.00
278,697.00
198,615.00
167,042.00
Net Non Operating Interest Income Expense
4,493.00
-488.00
-2,905.00
-105.00
307.00
Other Income Expense
3,251.00
-655.00
7,068.00
3,342.00
1,183.00
Pretax Income
362,434.00
335,682.00
282,860.00
201,852.00
168,532.00
Tax Provision
49,927.00
52,872.00
37,492.00
20,004.00
23,148.00
Net Income Common Stockholders
312,320.00
282,619.00
245,211.00
181,390.00
144,925.00
Diluted NI Available to Com Stockholders
312,320.00
282,619.00
245,211.00
181,390.00
144,925.00
Basic EPS
10.17
--
7.57
5.06
4.07
Diluted EPS
9.81
--
7.28
4.81
3.84
Basic Average Shares
30,680.75
--
32,388.00
35,862.00
35,635.00
Diluted Average Shares
31,802.50
--
33,671.00
37,697.00
37,708.00
Total Operating Income as Reported
354,690.00
336,825.00
278,697.00
198,615.00
167,042.00
Total Expenses
1,608,122.00
1,549,017.00
1,181,299.00
943,762.00
758,883.00
Net Income from Continuing & Discontinued Operation
312,507.00
282,810.00
245,368.00
181,848.00
145,384.00
Normalized Income
314,170.27
284,434.22
242,022.25
179,344.12
144,940.60
Net Interest Income
4,493.00
-488.00
-2,905.00
-105.00
307.00
EBIT
354,690.00
336,825.00
278,697.00
198,615.00
167,042.00
EBITDA
382,052.00
363,153.00
301,038.00
219,734.00
186,570.00
Reconciled Cost of Revenue
1,413,354.00
1,361,337.00
1,027,558.00
814,222.00
647,199.00
Reconciled Depreciation
27,362.00
26,328.00
22,341.00
21,119.00
19,528.00
Net Income from Continuing Operation Net Minority Interest
312,507.00
282,810.00
245,368.00
181,848.00
145,384.00
Total Unusual Items Excluding Goodwill
-1,929.00
-1,929.00
3,859.00
2,779.00
514.00
Total Unusual Items
-1,929.00
-1,929.00
3,859.00
2,779.00
514.00
Normalized EBITDA
383,981.00
365,082.00
297,179.00
216,955.00
186,056.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-265.73
-304.78
513.25
275.12
70.60
12/31/2020 - 8/11/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TMO Thermo Fisher Scientific Inc.
571.73
-0.98%
 
DHR Danaher Corporation
245.80
-1.84%
 
ICLR ICON Public Limited Company
300.08
-3.02%
 
IDXX IDEXX Laboratories, Inc.
489.24
-1.02%
 
MTD Mettler-Toledo International Inc.
1,232.91
-0.20%
 
IQV IQVIA Holdings Inc.
233.98
-2.85%
 
DGX Quest Diagnostics Incorporated
135.42
-1.55%
 
WAT Waters Corporation
308.35
-0.61%
 
GH Guardant Health, Inc.
17.16
-5.19%
 
A Agilent Technologies, Inc.
136.37
-0.81%